BMO Capital analyst Jeffrey Silber initiated coverage of CBIZ (CBZ) with an Outperform rating and $33 price target The firm says the company operates in a “fragmented, regulation-driven industry with favorable long-term demand characteristics.” CBIZ’s November 2024 Marcum acquisition doubled its market share and expanded its national scale, and its 72% recurring revenue mix provides stability, the analyst tells investors in a research note. BMO says the stock’s recent selloff brings an attractive entry point.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBZ:
- CBIZ: Attractive Buy Opportunity in a Fragmented, Regulation-Driven Market Post-Marcum Acquisition
- CBIZ Inc. Maps Post-Merger Path to Steady Growth
- CBIZ price target lowered to $40 from $60 at Deutsche Bank
- CBIZ reports Q4 adjusted EPS (70c), consensus (66c)
- CBIZ sees FY26 adjsuetd EPS $3.75-$3.85, consensus $3.85
